GCG and Hypoglycemia: A study reveals that only 13% of caregivers were able to administer the full dose of injectable glucagon during a simulated severe hypoglycemia event, proving the practical challenges with these formulations [30]. Due to this, injectable glucagon is often underused and underprescribed, which limits its overall impact as a life-saving treatment.